Skip to main content
The BMJ logoLink to The BMJ
. 1996 Jun 8;312(7044):1454–1456. doi: 10.1136/bmj.312.7044.1454

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.

A P Johnson 1, D C Speller 1, R C George 1, M Warner 1, G Domingue 1, A Efstratiou 1
PMCID: PMC2351209  PMID: 8664623

Abstract

OBJECTIVE--To assess the prevalence of antibiotic resistance and serotype distribution among pneumococci in England and Wales in 1990 and 1995. DESIGN--Observational surveys in March 1990 and March 1995. During two weeks in each survey period all pneumococci isolated in public health laboratories in England and Wales were collected and assessed for sensitivity to antibiotics and the distribution of serogroups or serotypes. SETTING--The network of public health laboratories throughout England and Wales. SUBJECTS--1127 individual patient isolates of Streptococcus pneumoniae obtained during the two surveys. MAIN OUTCOME MEASURES--Sensitivity or resistance to a range of antibiotics; serogroup or serotype. RESULTS--The prevalence of intermediate or full resistance to penicillin increased from 1.5% in 1990 to 3.9% in 1995 and resistance to erythromycin increased from 2.8% to 8.6%. About 92% of isolates belonged to serogroups or serotypes included in the currently available pneumococcal vaccine. CONCLUSION--Resistance to penicillin and erythromycin has increased among pneumococci in England and Wales. Continued surveillance to assess further increases in the prevalence of pneumococcal resistance to antibiotics is essential.

Full text

PDF
1454

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Fuchs P. C. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrob Agents Chemother. 1995 Jan;39(1):238–240. doi: 10.1128/aac.39.1.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boswell T. C., Nye K. J., Smith E. G. Penicillin- and penicillin-cephalosporin-resistant pneumococcal septicaemia. J Antimicrob Chemother. 1994 Nov;34(5):844–845. doi: 10.1093/jac/34.5.844. [DOI] [PubMed] [Google Scholar]
  3. Johnson A. P., Speller D. C., Patel B. C. Sensitivity to cefotaxime of pneumococci isolated in the UK. J Antimicrob Chemother. 1995 Mar;35(3):443–444. doi: 10.1093/jac/35.3.443. [DOI] [PubMed] [Google Scholar]
  4. Jorgensen J. H., Swenson J. M., Tenover F. C., Ferraro M. J., Hindler J. A., Murray P. R. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol. 1994 Oct;32(10):2448–2459. doi: 10.1128/jcm.32.10.2448-2459.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klein D. L. Pneumococcal conjugate vaccines: review and update. Microb Drug Resist. 1995 Spring;1(1):49–58. doi: 10.1089/mdr.1995.1.49. [DOI] [PubMed] [Google Scholar]
  6. Klugman K. P., Friedland I. R., Bradley J. S. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother. 1995 Sep;39(9):1988–1992. doi: 10.1128/aac.39.9.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lonks J. R., Medeiros A. A. High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. Antimicrob Agents Chemother. 1993 Sep;37(9):1742–1745. doi: 10.1128/aac.37.9.1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ridgway E. J., Allen K. D., Galloway A., Rigby A., O'Donoghue M. Penicillin-resistant pneumococci in a Merseyside hospital. J Hosp Infect. 1991 Jan;17(1):15–23. doi: 10.1016/0195-6701(91)90073-h. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES